Biosimilars Market - Top Companies and Manufacturers

Companies Dominating the Biosimilars Landscape

Biocon Limited
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Amgen Inc.
Novartis AG
Intas Pharmaceuticals Ltd.
BioXpress Therapeutics SA
Genor Biopharma Co. Ltd
Allergan plc (AbbVie Inc.)
Coherus BioSciences, Inc.
Pfizer Inc.
Reliance Life Sciences Private Limited

Browse Key Market Insights with Data Illustration:

Biosimilars Market Size & Share, Global Forecast Report 2037

In the News

Biocon Limited - Abevmy (bBevacizumab) is now available in Canada. It is co-developed by Biocon Biologics (a subsidiary of Biocon Limited) and Viatris and is a biosimilar to Roche’s Avastin (Bevacizumab). Health Canada has approved the drug for four oncology indications.
Amgen Inc., - announced the approval of RIABNI (rituximab-arrx), a biosimilar to Rituxan (rituximab) by the U.S. Food and Drug Administration (FDA). It is used for the treatment of adult patients with Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Granulomatosis with Polyangiitis (GPA) (Wegener's Granulomatosis), and Microscopic Polyangiitis (MPA).

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of biosimilars is evaluated at USD 32.16 billion.

The biosimilars market size was valued at USD 27.11 billion in 2024 and is expected to exceed USD 415.92 billion by the end of 2037, registering over 23.1% CAGR during the forecast period i.e., between 2025-2037. Rising burden of various diseases as well as a reduction in direct spending on biologics along with increasing development and commercialization of biosimilars will propel the market growth.

Europe is poised to dominate majority industry share by 2037, propelled by presence of a strong healthcare network in the region, and the growing number of hospitals and diseases.

The major players in the market include Biocon Limited, Amgen Inc., Novartis AG, Intas Pharmaceuticals Ltd., BioXpress Therapeutics SA, Genor Biopharma Co. Ltd, Allergan plc (AbbVie Inc.), Coherus BioSciences, Inc., Pfizer Inc., Reliance Life Sciences Private Limited.

Biosimilars Market - Top Companies and Manufacturers

Companies Dominating the Biosimilars Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the biosimilars market?

What are the factors driving the biosimilars landscape?

Which region held the largest biosimilars industry share?

Who are the key players in the biosimilars sector?